Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S4KI
|
|||
| Former ID |
DIB013747
|
|||
| Drug Name |
Menitorix
|
|||
| Synonyms |
Hib-MenC; Neisseria meningitidis C/Haemophilus influenzae b vaccine, GlaxoSmithKline; Vaccine (meningitis C, hemophilus influenza b), GlaxoSmithKline; Vaccine (meningitis C, hemophilus influenza b), SmithKline Beecham
Click to Show/Hide
|
|||
| Indication | Haemophilus influenza [ICD-11: 1G40; ICD-10: B96.3] | Approved | [1], [2] | |
| Company |
SmithKline Beecham plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00454987) Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.